Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR Completes Enrolment in Pivotal Phase 3

Jun 14, 2026 at 11:32 PM UTC · Listcorp

Paradigm Biopharmaceuticals Ltd. has released a press release.

View Attachment

Earlier from Paradigm Biopharmaceuticals

All Paradigm Biopharmaceuticals news releases